fda drug safety communication semaglutide naion 2025 GLP-1 Receptor Agonists and vision risk Ozempic Vision Loss Warning: EMA

This method is especially effective for rehydration, correcting nutrient deficiencies, supporting immune health, and providing symptom relief for a variety of conditions

It belongs to a class of drugs known as dual GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptor agonists

Compounded semaglutide is HSA and FSA eligible, allowing eligible patients to reduce their effective monthly cost by 2030% through tax-advantaged spending

Neurol Int 16:13181331

At Kypha our focus is on the development of new complement protein diagnostics that hold the promise of speeding up diagnosis of complement mediated diseases, including rare kidney disease such as C3G